Acute graft-versus-host disease II-IV in 1465 patients: has outcome improved over the past two decades?

被引:0
|
作者
Bacigalupo, A. [1 ]
Lamparelli, T. [1 ]
Varaldo, R. [1 ]
Frassoni, F. [1 ]
Raiola, A. M. [1 ]
Di Grazia, C. [1 ]
Bregante, S. [1 ]
Dominietto, A. [1 ]
Van Lint, M. T. [1 ]
机构
[1] S Martinos Hosp, Genoa, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S64 / S64
页数:1
相关论文
共 50 条
  • [1] Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease
    Marks, D.
    Kibbler, C.
    Cook, G.
    Pagliuca, A.
    Reisman, A.
    Miller, P.
    Kantecki, M.
    Schlamm, H.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S209 - S210
  • [2] Erratum: Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease
    D Marks
    C Kibbler
    G Cook
    A Pagliuca
    A Reisman
    P Miller
    M Kantecki
    H Schlamm
    Bone Marrow Transplantation, 2010, 45 : 1578 - 1578
  • [3] Impact of grade II-IV graft-versus-host disease (GVHD) on survival in patients with non-remission acute leukemia.
    Ohnishi, M
    Kanda, Y
    Iijima, K
    Ando, T
    Hamaki, T
    Nakai, K
    Saito, T
    Kami, M
    Makimoto, A
    Tanosaki, R
    Takaue, Y
    Mineishi, S
    BLOOD, 2001, 98 (11) : 359B - 360B
  • [4] Improved Overall Survival in Patients with Grade III and IV Acute Graft-Versus-Host Disease
    El-Jawahri, Areej
    Li, Shuli
    Coughlin, Erin
    Ho, Vincent T.
    Alyea, Edwin P., III
    Armand, Philippe
    Ballen, Karen K.
    Dey, Bimalangshu R.
    Glotzbecker, Brett
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S265 - S265
  • [5] ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CML
    GRATWOHL, A
    HERMANS, J
    APPERLEY, J
    ARCESE, W
    BACIGULAPO, A
    BANDINI, G
    BOOGAERTS, M
    BOSI, A
    CARRERAS, E
    DEVERGIE, A
    FERRANT, A
    FIBBE, WE
    FRASSONI, F
    GAHRTON, G
    GOLDMAN, J
    IRIONDO, A
    JACOBSEN, N
    LINK, H
    KOLB, HJ
    MICHALLET, M
    PRENTICE, HG
    REIFFERS, J
    VANRHEE, F
    RUUTU, T
    TORLONTANO, G
    SCHWEIKOFER, H
    VERNANT, JP
    DEWITTE, T
    NIEDERWIESER, D
    BLOOD, 1994, 84 (10) : A539 - A539
  • [6] A THREE BIOMARKER PANEL AT DAYS 7 AND 14 CAN PREDICT DEVELOPMENT OF GRADE II-IV ACUTE GRAFT-VERSUS-HOST DISEASE
    Paczesny, S.
    Braun, T.
    Vander Lugt, M.
    Harris, A.
    Fiema, B.
    Hernandez, J.
    Choi, S. W.
    Kitko, C.
    Magenau, J.
    Yanik, G.
    Peres, E. M.
    Pawarode, A.
    Mineishi, S.
    Whitfield, J.
    Jones, D.
    Couriel, D.
    Pavan, R.
    Hanash, S.
    Ferrara, J. L. M.
    Levine, J. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S167 - S167
  • [7] Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease
    Paczesny, Sophie
    Braun, Thomas
    Vander Lugt, Mark
    Harris, Andrew
    Fiema, Bryan
    Hernandez, James
    Choi, Sung
    Kitko, Carrie
    Magenau, John
    Yanik, Gregory
    Peres, Edward M.
    Pawarode, Attaphol
    Mineishi, Shin
    Whitfield, Joel
    Jones, Dawn
    Couriel, Daniel
    Reddy, Pavan
    Hanash, Samir
    Ferrara, James L. M.
    Levine, John E.
    BLOOD, 2010, 116 (21) : 296 - 297
  • [8] Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease (vol 45, pg 1578, 2010)
    Marks, D.
    Kibbler, C.
    Cook, G.
    Pagliuca, A.
    Reisman, A.
    Miller, P.
    Kantecki, M.
    Schlamm, H.
    BONE MARROW TRANSPLANTATION, 2010, 45 (10) : 1578 - 1578
  • [9] ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    GRATWOHL, A
    HERMANS, J
    APPERLEY, J
    ARCESE, W
    BACIGALUPO, A
    BANDINI, G
    DIBARTOLOMEO, P
    BOOGAERTS, M
    BOSI, A
    CARRERAS, E
    DEVERGIE, A
    FERRANT, A
    FIBBE, WE
    FRASSONI, F
    GAHRTON, G
    GOLDMAN, J
    IRIONDO, A
    JACOBSEN, N
    KOLB, HJ
    LINK, H
    MICHALLET, M
    PRENTICE, HG
    REIFFERS, J
    VONRHEE, F
    RUUTU, T
    SCHWAIGHOFER, H
    VERNANT, JP
    DEWITTE, T
    NIEDERWIESER, D
    BLOOD, 1995, 86 (02) : 813 - 818
  • [10] INTENSIFICATION OF GVHD PROPHYLAXIS INTERFERES WITH THE EFFECTS OF PRETRANSPLANT HERPES-VIRUS SEROLOGY ON THE OCCURRENCE OF GRADES II-IV ACUTE GRAFT-VERSUS-HOST DISEASE
    GRATAMA, JW
    VANDERNAT, H
    WEILAND, HT
    STIJNEN, T
    FIBBE, WE
    VOSSEN, JMJJ
    WILLEMZE, R
    VERDONCK, LF
    ANNALS OF HEMATOLOGY, 1992, 64 : A137 - A139